125 related articles for article (PubMed ID: 37244053)
1. A review on the role of GHET1 in different cancers.
Ghafouri-Fard S; Ahmadi Teshnizi S; Hussen BM; Taheri M; Zali H
Pathol Res Pract; 2023 Jul; 247():154545. PubMed ID: 37244053
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
4. lncRNA GHET1 down-regulation suppresses the cell activities of glioma.
Ni W; Luo L; Zuo P; Li RP; Xu XB; Wen F; Hu D
Cancer Biomark; 2018; 23(1):9-22. PubMed ID: 30103301
[TBL] [Abstract][Full Text] [Related]
5. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
Jin L; He Y; Tang S; Huang S
J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
[TBL] [Abstract][Full Text] [Related]
6. LncRNA GHET1 promotes esophageal squamous cell carcinoma cells proliferation and invasion via induction of EMT.
Liu H; Zhen Q; Fan Y
Int J Biol Markers; 2017 Oct; 32(4):e403-e408. PubMed ID: 28983895
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Long Noncoding RNA GHET1 Inhibits Cell Proliferation and Invasion of Colorectal Cancer.
Zhou J; Li X; Wu M; Lin C; Guo Y; Tian B
Oncol Res; 2016; 23(6):303-9. PubMed ID: 27131316
[TBL] [Abstract][Full Text] [Related]
8. GHET1 acts as a prognostic indicator and functions as an oncogenic lncRNA in cervical cancer.
Zhang Q; Zhang Y; Wang Y
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30948501
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA GHET1 promotes the development of bladder cancer.
Li LJ; Zhu JL; Bao WS; Chen DK; Huang WW; Weng ZL
Int J Clin Exp Pathol; 2014; 7(10):7196-205. PubMed ID: 25400817
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of LncRNA GHET1 expression in various cancers: a systematic review and meta-analysis.
Ye J; Sun H; Feng Z; Zhang Q; Xia Y; Ji Y; Zhang Q
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31227613
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
Yang F; Xue X; Zheng L; Bi J; Zhou Y; Zhi K; Gu Y; Fang G
FEBS J; 2014 Feb; 281(3):802-13. PubMed ID: 24397586
[TBL] [Abstract][Full Text] [Related]
13. LncRNA GHET1 promotes cervical cancer progression through regulating AKT/mTOR and Wnt/β-catenin signaling pathways.
Liu Z; Luo S; Wu M; Huang C; Shi H; Song X
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31682716
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Expression of Gastric Carcinoma High Expressed Transcript 1 is a Diagnostic and Prognostic Biomarker in Human Cancer.
Wang H; Meng F; Dong S
J Natl Med Assoc; 2020 Dec; 112(6):602-612. PubMed ID: 32653201
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Significance of Long Non-Coding RNA GHET1 in Human Cancers: A Meta-Analysis.
Poursheikhani A; Nokhandani N; Yousefi H; Rad DM; Sahebkar A
Curr Pharm Biotechnol; 2020; 21(14):1422-1432. PubMed ID: 32720600
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of long noncoding RNA GHET1 inhibits cell‑cycle progression and invasion of gastric cancer cells.
Xia Y; Yan Z; Wan Y; Wei S; Bi Y; Zhao J; Liu J; Liao DJ; Huang H
Mol Med Rep; 2018 Sep; 18(3):3375-3381. PubMed ID: 30066922
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA GHET1 in human cancer.
Li J; Jiang X; Li Z; Huang L; Zhou Y; Liu Y; Cui Y
Clin Chim Acta; 2019 Jan; 488():111-115. PubMed ID: 30399371
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer.
Guan ZB; Cao YS; Li Y; Tong WN; Zhuo AS
Cancer Biomark; 2018 Feb; 21(3):557-563. PubMed ID: 29286919
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA GHET1 promotes cell proliferation through oxidative stress in prostate cancer.
Wen Y; Huang H; Huang B; Liao X
J Biochem Mol Toxicol; 2023 Jul; 37(7):e23369. PubMed ID: 37029520
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of long-non-coding RNA GHET1 in pancreatic cancer.
Zhou HY; Zhu H; Wu XY; Chen XD; Qiao ZG; Ling X; Yao XM; Tang JH
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5081-5088. PubMed ID: 29228419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
